Medical Devices News and Research

RSS

FDA allows marketing of Stratify JCV Antibody ELISA test for PML

Today, the U.S. Food and Drug Administration allowed marketing of the first test to help determine the risk for a rare brain infection called progressive multifocal leukoencephalopathy (PML) in people using the drug Tysabri (natalizumab) to treat multiple sclerosis (MS) or Crohn's disease.

21 Jan 2012

Exposure to phthalates may increase risk of obesity in young children

Researchers from the Children's Environmental Health Center at The Mount Sinai Medical Center in New York have found an association between exposure to the chemical group known as phthalates and obesity in young children - including increased body mass index (BMI) and waist circumference.

20 Jan 2012

Drug benefit managers unveil ads to explain what they do

The trade group for pharmaceutical benefit managers announced an advertising campaign about PBMs, while Congress and federal regulators weigh a $29 billion merger between Express Scripts and Medco.

19 Jan 2012

Henry Ford to conduct Apnex HGNS System clinical trial in OSA

A clinical trial is underway at Henry Ford Hospital to evaluate the safety and effectiveness of the Apnex Hypoglossal Nerve Stimulation System to treat obstructive sleep apnea.

19 Jan 2012

Dogs with spinal cord injuries may soon benefit from experimental drug

Dogs with spinal cord injuries may soon benefit from an experimental drug being tested by researchers at the University of California, San Francisco (UCSF) and Texas A&M College of Veterinary Medicine & Biomedical Sciences — work that they hope will one day help people with similar injuries.

19 Jan 2012

Agilent's liquid chromatography and mass spec systems listed as Class I medical devices with FDA

Agilent Technologies Inc. (NYSE:A) today announced that it has listed its Infinity Series 1200 liquid chromatography systems and 6000 Series mass spectrometry systems as Class I medical devices with the U.S. Food and Drug Administration.

18 Jan 2012

PCORI to meet this week to release national priorities for medical effectiveness research

The Patient-Centered Outcomes Research Institute, an independent board established by the health law, will meet this week to set priorities for "comparative effectiveness research." In other news related to the health law, the News Hour reports on how the overahul has impacted pediatric cancer patients and the New York Times reports on the law's provisions related to screening kids for obesity and providing them counseling.

18 Jan 2012

VeriTeQ acquires PositiveID's VeriChip and Health Link web-based PHR

VeriTeQ Acquisition Corporation, a marketer of implantable, radio frequency identification technologies for patient identification and sensor applications, announced today it has acquired the VeriChip implantable microchip and related technologies, and Health Link personal health record from PositiveID Corporation.

18 Jan 2012

Bionime, GE enter licensing agreement to provide diabetes solutions

GE today announced it has entered into a new worldwide licensing agreement with Bionime, a global leader in biotechnology medical testing, to provide new GE-branded solutions for the diabetes market.

18 Jan 2012

MYTHOS clinical trial demonstrates superiority of RenalGuard in reducing CIN

PLC Systems Inc., a company focused on innovative medical device technologies, today announced that final results from the MYTHOS investigator-sponsored clinical trial of RenalGuard in Italy have been published in the January 2012 issue of JACC – Cardiovascular Interventions, a peer-reviewed journal of the American College of Cardiology.

13 Jan 2012

Health Secretary stands firm on the issue of removal of faulty breast implants

Britain’s Health Secretary Andrew Lansley intends to take cosmetic industry companies that are refusing free operations to women wanting substandard breast implants removed to court. Lansley is ready to take action after the declaration of the Harley Medical Group that it will not pay for removal of the PIP implants that have triggered great anxiety in women in the UK and in France. Transform and the Hospital Group have also said that women will have to pay.

12 Jan 2012

Turku University Hospital selects Ascom Miratel's IP-based Innova Nurse Call System

According to an agreement made with Turku University Hospital (TYKS), Ascom Miratel Oy will deliver the IP-based Innova Nurse Call System to the new Turku University Hospital extension during 2012. The deal consists of equipment to almost 200 patient beds in 24 wards and other care facilities. This order is the single largest in Ascom Miratel Oy's history to date, with a total value exceeding €700,000.

11 Jan 2012

Tobacco more harmful to lungs than marijuana

A large-scale national study suggests low to moderate use of marijuana is less harmful to users' lungs than exposure to tobacco, even though the two substances contain many of the same components. This comprehensive study, led by UCSF and University of Alabama at Birmingham, collected data from more than 5,000 U.S. adults for more than 20 years.

11 Jan 2012

Cardio3BioSciences raises €3.1M in non-dilutive funding

The Belgian biotechnology company, Cardio3BioSciences, a leader in the discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases, today announces it has secured a total of €3.1 million in non-dilutive funding from the Walloon Region and the European Commission's Seventh Framework Programme.

10 Jan 2012

More on the PIP breast implant scare

Model Jasmine Lennard underwent an emergency operation to replace her breast implants after discovering they contained banned silicone. The 26-year-old admits that she became ‘hysterical’ after discovering her implants came from French firm PIP, which is at the centre of a global health scare for using industrial-grade materials deemed unfit for medical use. And she believes last week’s procedure could have ‘saved my life’.

9 Jan 2012

Neomend receives PMA from FDA for Progel Extended Applicator Spray Tip

Neomend, Inc., a leading innovator in sealant and adhesion-prevention products for the surgical marketplace, said it has received premarket approval from the U.S. Food and Drug Administration for use of the company's new Progel Extended Applicator Spray Tip.

9 Jan 2012

Shire, ICON sign strategic partnership agreement

ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that is has signed a strategic partnership with Shire Specialty Pharmaceuticals to serve as the sole global provider of central laboratory services and one of two strategic partners for clinical development services.

9 Jan 2012

Georgia Bio announces 2012 Deals of the Year for pharma, biopharma and medical device companies

Georgia Bio announced its 2012 Deals of the Year for pharmaceutical, biopharmaceutical and medical device companies in four categories - public and private financings, fast growing companies, acquisitions and SBIR grants - reflecting a broad range of activity.

From Medtronic 7 Jan 2012

New Zealand life science and health IT companies to showcase their products in San Francisco

New Zealand is well known for its wines and stunning scenery, but the country is also a great source of innovation in the life sciences. A delegation of New Zealand life sciences companies who have reached key stages in their development are joining the throngs of international therapeutics, medical device and health IT companies in San Francisco, January 9 - 12 to showcase their products and capabilities to potential corporate partners and investors.

7 Jan 2012

VirtualScopics receives NASDAQ Stock Market notice

VirtualScopics, Inc., a leading provider of image-based solutions to the pharmaceutical, biotechnology and medical device industries, announced today that on January 4, 2012 it received a notice from the NASDAQ Stock Market indicating that the Company's minimum bid price has fallen below $1.00 for 30 consecutive business days.

7 Jan 2012